Clinical Trial Update: Investigation of a New Trial Drug (FE200486) in Prostate Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for FE200486 in prostate cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• FE200486

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2009-03-31